Cargando…

Different assessment tools to detect sarcopenia in patients with Parkinson's disease

INTRODUCTION: Sarcopenia and Parkinson's disease are closely related diseases of the elderly population leading to progressive disability and nursing-dependent care. OBJECTIVE: The aim of this study was to estimate the prevalence of sarcopenia in PD patients with three different approaches: (1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valent, Dora, Peball, Marina, Krismer, Florian, Lanbach, Anna, Zemann, Sophie, Horlings, Corinne, Poewe, Werner, Seppi, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742236/ https://www.ncbi.nlm.nih.gov/pubmed/36518192 http://dx.doi.org/10.3389/fneur.2022.1014102

Ejemplares similares

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease
por: Peball, Marina, et al.
Publicado: (2023)

Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
por: Ellmerer, Philipp, et al.
Publicado: (2022)

Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
por: Peball, Marina, et al.
Publicado: (2019)

Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
por: Heim, Beatrice, et al.
Publicado: (2023)

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
por: Peball, Marina, et al.
Publicado: (2022)

α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
por: Grossauer, Anna, et al.
Publicado: (2023)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Differentiating Parkinson’s Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis
por: Heim, Beatrice, et al.
Publicado: (2022)

Magnetic resonance imaging for the diagnosis of Parkinson’s disease
por: Heim, Beatrice, et al.
Publicado: (2017)

Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis
por: Bajaj, Sweta, et al.
Publicado: (2017)

Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis
por: Heim, Beatrice, et al.
Publicado: (2021)

The Concept of Prodromal Parkinson’s Disease
por: Mahlknecht, Philipp, et al.
Publicado: (2015)

Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease
por: Krismer, Florian, et al.
Publicado: (2020)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson’s disease
por: Hametner, Eva-Maria, et al.
Publicado: (2012)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Prodromal Parkinson's disease: hype or hope for disease-modification trials?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
por: Grossauer, Anna, et al.
Publicado: (2023)

Undetected ophthalmological disorders in Parkinson’s disease
por: Borm, Carlijn D. J. M., et al.
Publicado: (2022)

Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease
por: Mahlknecht, Philipp, et al.
Publicado: (2016)

Gait and postural disorders in parkinsonism: a clinical approach
por: Raccagni, Cecilia, et al.
Publicado: (2019)

Has Deep Brain Stimulation Changed the Very Long‐Term Outcome of Parkinson's Disease? A Controlled Longitudinal Study
por: Mahlknecht, Philipp, et al.
Publicado: (2020)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)

Towards seeing the visual impairments in Parkinson’s disease: protocol for a multicentre observational, cross-sectional study
por: Borm, Carlijn D. J. M., et al.
Publicado: (2019)

Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Cai, Yingying, et al.
Publicado: (2021)

Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
por: Eckhardt, Christine, et al.
Publicado: (2022)

Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis
por: Krismer, Florian, et al.
Publicado: (2019)

Sensitivity to Change and Patient‐Centricity of the Unified Multiple System Atrophy Rating Scale Items: A Data‐Driven Analysis
por: Krismer, Florian, et al.
Publicado: (2022)

Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off
por: Kuoppamäki, Mikko, et al.
Publicado: (2015)

Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)
por: Esterhammer, Regina, et al.
Publicado: (2015)

Sensor‐based gait analysis in atypical parkinsonian disorders
por: Raccagni, Cecilia, et al.
Publicado: (2018)

No effect of age, gender and total intracranial volume on brainstem MR planimetric measurements
por: Mangesius, Stephanie, et al.
Publicado: (2020)

Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
por: Kühnel, Line, et al.
Publicado: (2022)

Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
por: LeWitt, Peter A., et al.
Publicado: (2012)

Hospital Admissions of Huntington's Disease Patients in a Huntington's Disease Centre Between 2011 and 2016: A Retrospective Analysis
por: Peball, Marina, et al.
Publicado: (2022)

Holter STAT-ON™ against other tools for detecting MF in advanced Parkinson’s disease: an observational study
por: Cabo-Lopez, Iria, et al.
Publicado: (2023)

Augmentation in restless legs syndrome: an eye tracking study on emotion processing
por: Ellmerer, Philipp, et al.
Publicado: (2020)

Predictors of Response for “Off” Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry
por: Poewe, Werner, et al.
Publicado: (2020)

The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
por: Rocha, José-Francisco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uc32b0sqpc7ch043st5epvdbpo